Matthew Vincent Dolan, EVP, Strategy & Corporate Dev: Dexcom DXCM Sell · Filed 25/01/30

Trade details

Type: Insider sale
Amount: $102,814.53
Shares · price: 1,183 sh · $86.91 a share
Held after: 42,044 sh
Stock: Dexcom DXCM
Person: Matthew Vincent DolanEVP, Strategy & Corporate Dev
Trade date: 25/01/29
Filed: 25/01/30
Days to filing: 1 days

Sold 2.7% of holdings

Share of holding sold: 2.7%

Dexcom trades, last 26 weeks

What else happened in Dexcom around then

Filed or reported within 30 days of the trade day · 24/12/30~25/02/28

Matthew Vincent Dolan's recent trades

Matthew Vincent DolanEVP Strategy and Corporate Dev
Sell10b5-1 planDexcom
Sell10b5-1 plan
Dexcom
DXCM
$306.7K
2,423 sh
$306.7K
Filed 24/05/16
Traded 24/05/15
Matthew Vincent DolanEVP Strategy and Corporate Dev
Sell10b5-1 planDexcom
Sell10b5-1 plan
Dexcom
DXCM
$274.2K
1,990 sh
$274.2K
Filed 24/04/16
Traded 24/04/15
Matthew Vincent DolanEVP Strategy & Corp Dev
Sell10b5-1 planDexcom
Sell10b5-1 plan
Dexcom
DXCM
$243.6K
1,886 sh
$243.6K
Filed 24/03/19
Traded 24/03/15
Matthew Vincent DolanEVP Strategy & Corp Dev
Sell10b5-1 planDexcom
Sell10b5-1 plan
Dexcom
DXCM
$171.8K
1,314 sh
$171.8K
Filed 24/03/19
Traded 24/03/15
Matthew Vincent DolanEVP Strategy & Corp Dev
Sell10b5-1 planDexcom
Sell10b5-1 plan
Dexcom
DXCM
$131.8K
1,003 sh
$131.8K
Filed 24/03/19
Traded 24/03/15